KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Long-Term Debt Issuances (2016 - 2025)

Boston Scientific's Long-Term Debt Issuances history spans 14 years, with the latest figure at $1.6 billion for Q1 2025.

  • For Q1 2025, Long-Term Debt Issuances fell 27.37% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 27.37%, while the annual FY2025 figure was $1.6 billion, 27.37% down from the prior year.
  • Long-Term Debt Issuances for Q1 2025 was $1.6 billion at Boston Scientific, down from $2.1 billion in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $3.3 billion in Q1 2022 and bottomed at -$1.0 million in Q2 2022.
  • The 3-year median for Long-Term Debt Issuances is $1.9 billion (2024), against an average of $1.7 billion.
  • The largest YoY upside for Long-Term Debt Issuances was 27.37% in 2025 against a maximum downside of 27.37% in 2025.
  • A 3-year view of Long-Term Debt Issuances shows it stood at -$1.0 million in 2022, then skyrocketed by 214600.0% to $2.1 billion in 2024, then dropped by 27.37% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Long-Term Debt Issuances are $1.6 billion (Q1 2025), $2.1 billion (Q1 2024), and -$1.0 million (Q2 2022).